Identifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role
May 14, 2026 - 00:14:45
Radio and PodcastLive Radio & PodcastsHealth
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
Host: Ryan Quigley A new multicenter study highlights how serum and CSF biomarkers can refine prognostic accuracy and guide treatment strategies in multiple sclerosis (MS). ReachMD's Ryan Quigley explains key findings an...
About This Episode
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers is an episode from NeuroFrontiers by ReachMD. Host: Ryan Quigley A new multicenter study highlights how serum and CSF biomarkers can refine prognostic accu...
Podcast
This episode belongs to NeuroFrontiers.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Sep 17, 2025, 00:04:30 long, audio available.
Related Episodes
Continue listening to more episodes from NeuroFrontiers.
Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols
May 14, 2026 - 00:13:30
Understanding Variability in Myasthenia Gravis
May 1, 2026 - 00:03:45
Examining the Global Genetic Prevalence of TK2d
Apr 30, 2026 - 00:14:01
Advances in Cell-Based Therapy for MS
Apr 20, 2026 - 00:03:15
Next-Generation MS Care: The Promise of Cell-Based Therapeutics
Apr 20, 2026 - 00:03:00
Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
Mar 30, 2026 - 00:03:00
Proactive Pregnancy Planning and Reproductive Care in MS
Mar 30, 2026 - 00:03:00
Questions About This Episode
What is Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers about?
Host: Ryan Quigley A new multicenter study highlights how serum and CSF biomarkers can refine prognostic accuracy and guide treatment strategies in multiple sclerosis (MS). ReachMD's Ryan Quigley explains key findings and provides insights on how integrating these biomarkers at diagnosis could move MS care toward more personalized and effective interventions. This topic was also discussed at the 2025 Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
Where can I listen to Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers?
You can listen to Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers from?
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers is an episode from NeuroFrontiers by ReachMD.
How long is this episode?
This episode is 00:04:30 long.
When was this episode published?
This episode was published on Sep 17, 2025.
Can I save Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from NeuroFrontiers?
Yes. This page shows related episodes from NeuroFrontiers when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers?
You can listen to Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers is from NeuroFrontiers by ReachMD.
What are the episode details?
Published Sep 17, 2025 and 00:04:30 long